Strategic IP Consulting

IP Planning	«
IP Audits & Due Diligence	«
IP SWOT Analysis	«
IP Valuation	«
IP Corporate Governance and Policies	«
IP Tax Planning	«
IP strategies for the Pharma & Biotech Industry	«

Back to practices

Strategic IP Consulting: Services

IP strategies for the Pharma & Biotech Industry

A particular challenge lies ahead for many innovative pharmaceutical companies in formulating their intellectual property strategy in a very early stage, even years before patents expire. ipeg provides its pharma clients with an analysis to anticipate patent expiration
and patent invalidity risks well in advance of their actual occurrence (risk/opportunity assessment) for drugs on or close to the market.

ipeg also analyses its client’s IP portfolio in the “third” tier (i.e. not related to drugs on or close to the market) to create long-term suitable valorisation options whenever possible.